CAXTON ASSOCIATES LP – Prelude Therapeutics Incorporated Transaction History
CAXTON ASSOCIATES LP portfolio value:
$568,000
portfolio value
CAXTON ASSOCIATES LP quarter portfolio value change:
+26.63%
quarter
Prelude Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.53% | 2.12K shares | 130K | $6.61 | 85.99K |
| Q2 2022 | share | Increase | 0.00% | 83.86K shares | 438K | $5.22 | 83.86K |